CARB-X Continuing grant for Phase-1 Clinical Trial
GARDP grant to support a part of Phase-1 Clinical Trial
CARB-X Continuing grant for preclinical development
CARB-X Continuing grant for preclinical development
Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding
Bugworks gets CARB-X funding
DBT-BIPP Continuing grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”
DBT-BIPP grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”
BIG Grant: Reverse MOA For deciphering the target for anti-bacterial compounds emerging from phenotypic screens
Discovery of novel combinations for tuberculosis through NIH contract services, USA
